BioNxt Solutions Inc. (BNXT.CN)
CAD 0.32
(1.61%)
CAD 0.32
(1.61%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -6.48 Million CAD | -8.01% |
| 2022 | -11.51 Million CAD | 62.38% |
| 2021 | -19.19 Million CAD | -10.87% |
| 2020 | -16.05 Million CAD | -125.37% |
| 2019 | -6.66 Million CAD | -700.53% |
| 2018 | -758.14 Thousand CAD | -17106.63% |
| 2017 | -4480.00 CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -712.8 Thousand CAD | 46.81% |
| 2024 Q1 | -1.32 Million CAD | 38.45% |
| 2023 Q1 | -1.27 Million CAD | 28.25% |
| 2023 Q4 | -2.01 Million CAD | -94.16% |
| 2023 FY | - CAD | -8.01% |
| 2023 Q2 | -1.95 Million CAD | -53.05% |
| 2023 Q3 | -1.03 Million CAD | 46.98% |
| 2022 Q2 | -1.57 Million CAD | -17.44% |
| 2022 FY | - CAD | 62.38% |
| 2022 Q4 | -1.77 Million CAD | -62.07% |
| 2022 Q1 | -1.34 Million CAD | 69.7% |
| 2022 Q3 | -1.09 Million CAD | 30.51% |
| 2021 Q2 | -3.76 Million CAD | 24.79% |
| 2021 Q1 | -5.01 Million CAD | -87.99% |
| 2021 Q3 | -2.2 Million CAD | 41.59% |
| 2021 Q4 | -4.43 Million CAD | -101.63% |
| 2021 FY | - CAD | -10.87% |
| 2020 Q4 | -2.66 Million CAD | 42.49% |
| 2020 Q2 | -3.3 Million CAD | -0.3% |
| 2020 Q1 | -3.29 Million CAD | -121.1% |
| 2020 FY | - CAD | -125.37% |
| 2020 Q3 | -4.63 Million CAD | -40.1% |
| 2019 Q4 | -1.49 Million CAD | 57.0% |
| 2019 FY | - CAD | -700.53% |
| 2019 Q3 | -3.46 Million CAD | -186.73% |
| 2019 Q2 | -1.2 Million CAD | -117.61% |
| 2019 Q1 | -555.99 Thousand CAD | -39.48% |
| 2018 Q1 | -83.72 Thousand CAD | 0.0% |
| 2018 Q2 | -276.32 Thousand CAD | -230.05% |
| 2018 FY | - CAD | -17106.63% |
| 2018 Q4 | -398.62 Thousand CAD | -378.73% |
| 2018 Q3 | -83.26 Thousand CAD | 69.87% |
| 2017 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Aion Therapeutic Inc. | -6.07 Million CAD | -6.765% |
| Ayurcann Holdings Corp. | -2.01 Million CAD | -222.539% |
| Blueberries Medical Corp. | -1.22 Million CAD | -430.747% |
| The BC Bud Corporation | -1.19 Million CAD | -442.185% |
| CordovaCann Corp. | -1.6 Million CAD | -304.626% |
| Christina Lake Cannabis Corp. | -2.62 Million CAD | -147.179% |
| Captor Capital Corp. | 2.42 Million CAD | 367.83% |
| City View Green Holdings Inc. | -2.01 Million CAD | -221.903% |
| 1CM Inc. | 1.31 Million CAD | 593.68% |
| Global Hemp Group Inc. | -24.79 Thousand CAD | -26055.02% |
| Greenway Greenhouse Cannabis Corporation | -2.2 Million CAD | -193.635% |
| IM Cannabis Corp. | -2.79 Million CAD | -132.423% |
| Lobe Sciences Ltd. | -4.4 Million CAD | -47.301% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -1553.327% |
| Mountain Valley MD Holdings Inc. | -3.19 Million CAD | -103.088% |
| Nextleaf Solutions Ltd. | 1.14 Million CAD | 668.028% |
| Ovation Science Inc. | -778.83 Thousand CAD | -732.608% |
| Pharmadrug Inc. | -1.33 Million CAD | -385.734% |
| Captiva Verde Wellness Corp. | -6.05 Million CAD | -7.076% |
| RAMM Pharma Corp. | -6.3 Million CAD | -2.896% |
| RIV Capital Inc. | -20.28 Million CAD | 68.025% |
| Revive Therapeutics Ltd. | -5.59 Million CAD | -15.9% |
| Red White & Bloom Brands Inc. | -77.59 Million CAD | 91.643% |
| SLANG Worldwide Inc. | -2.95 Million CAD | -119.764% |
| 1933 Industries Inc. | -10.03 Million CAD | 35.367% |
| Red Light Holland Corp. | -5.25 Million CAD | -23.379% |
| Top Strike Resources Corp. | -767.99 Thousand CAD | -744.358% |
| Xebra Brands Ltd. | -1.49 Million CAD | -333.755% |
| Adastra Holdings Ltd. | -1.41 Million CAD | -359.49% |